marketinsider

Investigation Alert: FIGS, FRSH, and UPST – Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm for Accountability of Management in Losses

Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm SAN DIEGO, Jan. 28, 2023 (GLOBE NEWSWIRE) — FIGS, Inc. (NYSE: FIGS) Introduction Johnson Fistel, LLP is currently conducting an investigation into potential claims against certain officers and directors of FIGS, Inc. If you are a long-term shareholder of FIGS who has held…

Read More

Jasper Therapeutics Successfully Completes Public Offering of Common Stock with Full Exercise of Underwriters’ Option

Jasper Therapeutics Successfully Completes Public Offering of Common Stock with Full Exercise of Underwriters’ Option REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) Jasper Therapeutics, a biotechnology company based in California, has recently made headlines with the successful completion of their public offering of common stock. This achievement marks…

Read More

Unleashing the Power of the Greenback: A Daily Market Commentary for Friday’s European Trading Session

Daily Market Commentary Friday’s European Trading Session As Friday’s European trading session gets underway, the greenback is still carrying a positive momentum. However, the upside for the greenback is limited. A more in-depth analysis of the GDP data reveals that the growth was, to a large extent, driven by inventories, and therefore likely to fizzle…

Read More

Playtech’s FY22 EBITDA Expected to Exceed $400M: A Look at the Future of Fintech

Playtech’s Strong EBITDA Expectations for 2022 Playtech (LON: PTEC) released a trading update on Thursday, revealing its expectations to end the financial year 2022 with at least €400 million in adjusted EBITDA. The expected figure is 26 percent higher than the previous year. Playtech’s Solid EBITDA Expectations The company highlighted that the upward dragging of…

Read More

Breaking News: Genelux Corporation Goes Public! Get the Scoop on Their IPO Pricing

Welcome to the Genelux Corporation IPO Announcement! What is Genelux Corporation? Genelux Corporation, affectionately known as Genelux, is a clinical-stage immunotherapy company with a laser focus on developing next-generation oncolytic viral immunotherapies. If you’re scratching your head at those fancy terms, don’t worry – you’re not alone. Essentially, they are working on cutting-edge treatments for…

Read More

Attention Investors: Don’t Miss the Deadline for the Class Action Lawsuit Against BioLineRx Ltd. – A Reminder from Glancy Prongay Murray LLP

Act Now: Deadline Approaching for BioLineRx Ltd. Investors Investors, Take Note: Don’t miss the March 6, 2023 deadline to file a lead plaintiff motion in the class action lawsuit against BioLineRx Ltd. If you purchased or acquired BioLineRx Ltd. American Depositary Shares (ADSs) between a certain period, you could be eligible to participate in the…

Read More

Revving Up for Success: The Booming Future of CNG Cylinders Market – Projections and Insights by Contrive Datum Insights Pvt. Ltd.

CNG Cylinders Market Is Expected To Reach around USD 2.6 Billion By 2030 Introduction According to a market research study published by Contrive Datum Insights, the goal of switching to cars that don’t put out any pollution is to improve China’s air quality, cut CO2 emissions, and make the country less reliant on energy from…

Read More